1 Min Read
Nov 8 (Reuters) - Orthocell Ltd
* Seeks trading halt pending announcement in relation to its application for European regulatory approval of its collagen medical device Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.